JPH11113592A - Production of d-amino acid - Google Patents

Production of d-amino acid

Info

Publication number
JPH11113592A
JPH11113592A JP28007397A JP28007397A JPH11113592A JP H11113592 A JPH11113592 A JP H11113592A JP 28007397 A JP28007397 A JP 28007397A JP 28007397 A JP28007397 A JP 28007397A JP H11113592 A JPH11113592 A JP H11113592A
Authority
JP
Japan
Prior art keywords
amino acid
genus
cells
producing
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP28007397A
Other languages
Japanese (ja)
Other versions
JP3834960B2 (en
Inventor
Wataru Hibino
渉 日比野
Ikumasa Onishi
幾正 大西
Shigemitsu Abe
重光 阿部
Kenzo Yokozeki
健三 横関
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP28007397A priority Critical patent/JP3834960B2/en
Publication of JPH11113592A publication Critical patent/JPH11113592A/en
Application granted granted Critical
Publication of JP3834960B2 publication Critical patent/JP3834960B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing D-amino acid used in the field of medicines, chemicals and cosmetics, in an industrially advantageous way using the corresponding acylated amino acid as raw material through making microorganisms having D-aminoacylase activity or a treatment product thereof act on the acylated amino acid to accumulate the aimed D-amino acid in the resulting reaction liquor. SOLUTION: This method for producing the objective D-amino acid comprises that the corresponding acylamino acid is subjected to a culture liquid, microbial cells or enzyme extract (after microbial cell treatment) of newly found microorganisms high in D-aminoacylase activity and belonging to the genus Arthrobacter, Corynebacterium, Erwinia, Escherichia, Flavobacterium, Nocardia, Protaminobacter, Rhodococcus, or Xanthomonas, and the aimed D-amino acid formed is collected.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は医薬品・化学品・化
粧品分野で使用されるD−アミノ酸の製造法に関するも
のである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing D-amino acids used in the fields of pharmaceuticals, chemicals and cosmetics.

【0002】[0002]

【従来の技術】従来、D−アミノ酸の製造法として、ア
シル化アミノ酸にD−アミノアシラーゼを作用させ、D
−アミノ酸を得る方法が知られている。D−アミノアシ
ラーゼの起源としては、シュードモナス(Pseudomona
s)属細菌(特開昭55−42534)、ストレプトミ
セス(Streptomyces)属細菌(特公昭53−3603
5)また、アルカリゲネス(Alcaligenes)属細菌(特
開昭64−5488)等が知られている。
2. Description of the Related Art Conventionally, as a method for producing a D-amino acid, D-aminoacylase is allowed to act on an acylated amino acid to produce D-amino acid.
-Methods for obtaining amino acids are known. As a source of D-aminoacylase, Pseudomonas (Pseudomona
s) Bacteria of the genus (JP-A-55-42534), bacteria of the genus Streptomyces (JP-B-53-3603)
5) Also, bacteria belonging to the genus Alcaligenes (JP-A-64-5488) are known.

【0003】しかしながら、今まで知られているD−ア
ミノアシラーゼはいずれも活性が低い欠点を有する。ま
た、活性を高めるために組み換え手法を用い、酵素活性
を増幅して用いる方法も検討されてはいる(Protein Ex
pression and purification第7巻、395頁 1996年)
が、アルカリゲネス属細菌の酵素を大腸菌で発現させる
ものであり、異種遺伝子組み換えによる方法であること
から、汎用性に乏しい。
[0003] However, all of the D-aminoacylases hitherto known have the disadvantage of low activity. In addition, a method of using a recombinant technique to enhance the activity and amplifying the enzyme activity has also been studied (Protein Ex
pression and purification Vol. 7, p. 395 (1996)
However, this is a method for expressing an enzyme of a bacterium belonging to the genus Alcaligenes in Escherichia coli, and is a method based on heterologous gene recombination, so that it is poor in versatility.

【0004】[0004]

【発明が解決しようとする課題】本発明は、D−アミノ
アシラーゼ活性の高い微生物、あるいはセルフクローニ
ング容易な微生物を検索し、それらのD−アミノアシラ
ーゼ活性の高い微生物を用いて工業的に実施するのに有
利なD−アミノ酸の製造方法を提供するものである。
DISCLOSURE OF THE INVENTION The present invention searches for a microorganism having a high D-aminoacylase activity or a microorganism which is easily self-cloned, and industrially implements the microorganism using those microorganisms having a high D-aminoacylase activity. The present invention provides a method for producing a D-amino acid which is advantageous for the above.

【0005】[0005]

【課題を解決するための手段】本発明者らは、上述の課
題を解決すべくD−アミノ酸の製造法について鋭意研究
を重ねた結果、新規に、アースロバクター(Arthrobacte
r )属、コリネバクテリウム(Corynebacterium)属、エ
ルビニア(Erwinia)属、エセリシア(Escherichia)属、
フラボバクテリウム(Flavobacterium)属、ノカルディア
(Nocardia)属、プロタミノバクター(Protaminobacter)
属、ロドコッカス(Rhodococcus)属またはキサントモナ
ス(Xanthomonas)属に属する微生物が、D−アミノアシ
ラーゼ活性を有し、アシルアミノ酸をD−アミノ酸に効
率的に変換する能力を有することを見いだし、この知見
に基づいて本発明を完成するに至った。
Means for Solving the Problems The present inventors have conducted intensive studies on a method for producing a D-amino acid in order to solve the above-mentioned problems. As a result, the present inventors have newly found an arthrobacter.
r) genus, Corynebacterium genus, Erwinia genus, Escherichia genus,
Flavobacterium, Nocardia
(Nocardia) genus, Protaminobacter
Microorganisms belonging to the genus, Rhodococcus or Xanthomonas have D-aminoacylase activity and have the ability to efficiently convert acyl amino acids to D-amino acids. Thus, the present invention has been completed.

【0006】すなわち、本発明は、アシルアミノ酸をD
−アミノ酸に変換する能力を有し、アースロバクター(A
rthrobacter)属、コリネバクテリウム(Corynebacteriu
m)属、エルビニア(Erwinia)属、エセリシア(Escher
ichia)属、フラボバクテリウム(Flavobacterium)
属、ノカルディア(Nocardia)属、プロタミノバクター
(Protaminobacter)属、ロドコッカス(Rhodococcus)
属またはキサントモナス(Xanthomonas)属に属する微
生物の培養物、該培養物より分離した微生物菌体もしく
は該微生物菌体の処理物をアシルアミノ酸に作用させ、
生成されるD−アミノ酸を採取することを特徴とするD
−アミノ酸の製造方法に関するものである。
That is, the present invention provides an
-Has the ability to convert to amino acids,
rthrobacter), Corynebacteriu
m) genus, Erwinia, Escheria
ichia), Flavobacterium
Genus, Nocardia, Protaminobacter, Rhodococcus
A culture of a microorganism belonging to the genus Xanthomonas or the genus Xanthomonas, a microbial cell isolated from the culture or a processed product of the microbial cell, acting on an acyl amino acid;
Collecting D-amino acids to be produced,
-It relates to a method for producing an amino acid.

【0007】[0007]

【発明の実施の形態】本発明において用いられる微生物
は、D−アミノアシラーゼ活性を有する、すなわちアシ
ルアミノ酸をD−アミノ酸に変換する能力を有する、ア
ースロバクター属、コリネバクテリウム属、エルビニア
属、エセリシア属、フラボバクテリウム属、ノカルディ
ア属、プロタミノバクター属、ロドコッカス属、及びキ
サントモナス属に属する微生物であればいずれのもので
もよいが、具体的には、下記に示す微生物を例示するこ
とができる。
DETAILED DESCRIPTION OF THE INVENTION The microorganism used in the present invention has a D-aminoacylase activity, that is, a genus of the genus Arthrobacter, Corynebacterium, Erwinia, which has the ability to convert acyl amino acids to D-amino acids. Any microorganisms belonging to the genus Eselicia, the genus Flavobacterium, the genus Nocardia, the genus Protaminobacterium, the genus Rhodococcus, and the genus Xanthomonas may be used.Specifically, the following microorganisms are exemplified. Can be.

【0008】アースロハ゛クター ハ゜ラフィニス(Arthrobacter paraffineus ) ATCC15590アースロハ゛クター ハ゜ラフィニス(Arthrobacter paraffineus) ATCC15591アースロハ゛クター ハ゜ラフィニス(Arthrobacter paraffineus) ATCC19064アースロハ゛クター ハ゜ラフィニス(Arthrobacter paraffineus) ATCC19065アースロハ゛クター ハイト゛ロカーホ゛ク゛ルタミカス(Arthrobacter hydrocarboglutamicus)ATCC15583コリネハ゛クテリウム アセトアシト゛フィラム(Corynebacterium acetoacidphilum) ATCC373コリネハ゛クテリウム キセロシス(Corynebacterium xerosis) ATCC13870エセリシア コリ(Escherichia coli ) AJ2606(FERM BP-477)エセリシア コリ(Escherichia coli ) ATCC13071エルヒ゛ニア アミロホ゛ア(Erwinia amylovora) IFO12687 フラホ゛ハ゛クテリウム スワネンセ(Flavobacterium sewanense) AJ2476(FERM BP-476)ノカルテ゛ィア アステロイテ゛ス(Nocardia asteroides)ATCC3318フ゜ロタミノハ゛クター アルホ゛フラフ゛ス (Protaminobacter alboflavus) ATCC8458ロト゛コッカス エリスリホ゜ラス (Rhodococcus erythripolis) ATCC11048ロト゛コッカス エスヒ゜ー (Rhodococcus sp.) ATCC15592キサントモナス シトリ (Xanthomonas citri) AJ2785(FERM P-3396) 上記菌株の内、エセリシア コリ(Escherichia coli ) AJ2606
(FERM BP-477)は、国際寄託当局:通商産業省工業技術
院微生物工業技術研究所(現、通商産業省工業技術院生
命工学工業技術研究所)に昭和48年4月25日に寄託
され、昭和58年4月25日にブダペスト条約に基づく
国際寄託に移管された受託番号FERM BP-477の菌株であ
り、フラホ゛ハ゛クテリウム スワネンセ(Flavobacterium sewanense)
AJ2476(FERM BP-476)は、同寄託当局に昭和48年4月
25日に寄託され、昭和58年4月25日にブダペスト
条約に基づく国際寄託に移管された受託番号FERM BP-47
6の菌株であり、キサントモナス シトリ (Xanthomonas citri) AJ
2785(FERM P-3396)は、同寄託当局に昭和51年1月2
7日に寄託された受託番号FERM P-3396の菌株である。
Arthrobacter paraffineus (Arthrobacter paraffineus) ATCC15590 ATCC15583 Corynebacterium acetoacidphilum ATCC373 Corynebacterium xerosis ATCC13870 Escherichia coli AJ2606 (FERM BP-477) Escherichia coli Eiacherica Escherichia coli Escherichia coli (Escherichia coli) (Escherichia coli) Flavobacterium sewanense AJ2476 (FERM BP-476) Nocartia Nocardia asteroides ATCC3318 Protaminebacterium alboflavus ATCC8458 Rhodococcus erythripolis ATCC11048 Rhodococcus sp. Escherichia coli AJ2606
(FERM BP-477) was deposited on April 25, 1973 in the International Depositary Authority: Institute of Microbial Industry and Technology, Ministry of International Trade and Industry (currently, Institute of Biotechnology and Industrial Technology, Ministry of International Trade and Industry). Strain No. FERM BP-477, which was transferred to an international deposit under the Budapest Treaty on April 25, 1983, and is a strain of Flavobacterium sewanense.
AJ2476 (FERM BP-476) was deposited with the depositary authority on April 25, 1973 and transferred to an international deposit under the Budapest Treaty on April 25, 1983, under accession number FERM BP-47.
6 strains, Xanthomonas citri AJ
2785 (FERM P-3396) was filed with the depositary authority on January 2, 1976.
It is a strain of Accession No. FERM P-3396 deposited on the 7th.

【0009】また、当該微生物を親株として人工的に変
異処理、あるいは、組み換えDNA操作を用いることによ
り、L−アミノアシラーゼ等の夾雑酵素活性を低減、も
しくは失活させた改良株、もしくはD−アミノアシラー
ゼ活性を増強した改良株を用いることも可能である。特
に、人工的変異処理により、夾雑酵素であるL−アミノ
アシラーゼを失活させた変異株の取得方法は、特開昭62
-126969、または特開昭62-126976に詳細が記載されてお
り、容易に取得することができることから、L−アミノ
アシラーゼを失活させた変異株を用いることにより、D
L体のアシルアミノ酸から光学純度の高いD−アミノ酸
製造が可能となる。
An improved strain in which the activity of contaminating enzymes such as L-aminoacylase has been reduced or inactivated by artificially using the microorganism as a parent strain for mutation treatment or recombinant DNA manipulation, or D-amino acid. It is also possible to use an improved strain having enhanced acylase activity. In particular, a method for obtaining a mutant in which the contaminating enzyme L-aminoacylase has been inactivated by artificial mutation treatment is disclosed in
-126969 or JP-A-62-126976, which can be easily obtained. Therefore, by using a mutant in which L-aminoacylase is inactivated,
Production of D-amino acids having high optical purity from L-amino acids is possible.

【0010】このような微生物の菌体を得るには、当該
微生物を適当な培地で培養増殖せしめるとよい。そのよ
うな培地には格別の制限はなく、通常の炭素源、窒素
源、無機イオン、更に必要に応じアミノ酸、ビタミン等
の有機栄養源を含む通常の培地でよい。炭素源として
は、グルコース、シュークロース、フラクトース、ガラ
クトース、ラクト−ス等の糖類、これら糖類を含有する
澱粉糖化液、甘藷糖蜜、甜菜糖蜜、ハイテストモラセ
ス、更には酢酸等の有機酸、エタノール等のアルコール
類、グリセリン等も使用される。窒素源としてはアンモ
ニアガス、アンモニア水、アンモニウム塩類、尿素、硝
酸塩類、その他補助的に使用される有機窒素源、例えば
油粕類、大豆加水分解液、カゼイン分解物、その他のア
ミノ酸、コーンスティープリカー、酵母または酵母エキ
ス、ペプトン等のペプチド類等が使用される。無機イオ
ンとしてはリン酸イオン、マグネシウムイオン、カルシ
ウムイオン、鉄イオン、マンガンイオン等が適宜添加さ
れる。また本発明の微生物にアミノ酸等の要求性物質が
ある場合には、その要求物質を添加しなければならな
い。
In order to obtain the cells of such a microorganism, the microorganism may be cultured and grown in an appropriate medium. Such a medium is not particularly limited, and may be an ordinary medium containing ordinary carbon sources, nitrogen sources, inorganic ions, and, if necessary, organic nutrients such as amino acids and vitamins. Examples of the carbon source include sugars such as glucose, sucrose, fructose, galactose, and lactose; starch saccharified solutions containing these sugars; sweet potato molasses, sugar beet molasses, hightest molasses; and organic acids such as acetic acid; ethanol; Alcohols, glycerin and the like are also used. As a nitrogen source, ammonia gas, aqueous ammonia, ammonium salts, urea, nitrates, and other organic nitrogen sources used as auxiliary substances, such as oil cakes, soybean hydrolysate, casein hydrolyzate, other amino acids, corn steep liquor, Peptides such as yeast or yeast extract and peptone are used. As the inorganic ions, phosphate ions, magnesium ions, calcium ions, iron ions, manganese ions, and the like are appropriately added. If the microorganism of the present invention has a required substance such as an amino acid, the required substance must be added.

【0011】微生物の培養条件にも格別の制限はなく、
例えば、好気的条件下にて、pH5ないし8、温度25な
いし40℃の範囲内でpH及び温度を適当に制御しつつ1
2〜48時間程度培養を行なえばよい。培養液のpH
は、無機あるいは有機の酸、アルカリ性物質、更には尿
素、炭酸カルシウム、アンモニアガスなどによって予め
定められた値に調節すればよい。
There are no particular restrictions on the conditions for culturing microorganisms.
For example, under aerobic conditions, pH and temperature are appropriately controlled within a range of 5 to 8 and a temperature of 25 to 40 ° C.
Culture may be performed for about 2 to 48 hours. PH of culture solution
May be adjusted to a predetermined value with an inorganic or organic acid, an alkaline substance, urea, calcium carbonate, ammonia gas or the like.

【0012】上記微生物をアシルアミノ酸に作用せしめ
る方法としては、かくして得られる微生物培養物をその
まま用いる方法、微生物培養物から遠心分離等により菌
体を分離し、これをそのままもしくは洗浄した後、緩衝
液、水等に再懸濁したものに、アシルアミノ酸を添加し
反応させる方法等がある。また、微生物菌体の処理物と
しては、菌体破砕物、アセトン処理菌体、凍結乾燥菌
体、あるいは、これらの菌体あるいは菌体処理物をポリ
アクリルアミドゲル法、カラギーナン法、アルギン酸法
等の公知の方法で固定化した菌体を用いることができ
る。更に、微生物菌体処理物としては、菌体抽出物もし
くはこれより公知の方法を組み合わせて精製取得したD
−アミノアシラーゼ活性を有する酵素も使用できる。こ
の場合、機械的磨砕菌体、超音波処理破砕菌体あるいは
リゾチーム等で処理して得られた菌体処理物から、D−
アミノアシラーゼ活性を有する画分を精製して用いれば
良く、その精製法としては、通常の酵素を精製する方
法、すなわち硫安分画、イオン交換クロマト分画、疎水
クロマト分画、アフィニティークロマト分画等を挙げる
ことができる。
The above-mentioned microorganisms can be reacted with acylamino acids by a method using the microorganism culture thus obtained as it is, by separating cells from the microorganism culture by centrifugation or the like, and washing or washing the same with a buffer solution. , Water and the like, and then reacting by adding an acyl amino acid. In addition, as a processed product of the microbial cells, crushed cells, acetone-treated cells, freeze-dried cells, or these cells or the processed cells are treated with a polyacrylamide gel method, a carrageenan method, an alginic acid method, or the like. The cells immobilized by a known method can be used. Further, as the treated microorganism cells, there may be used a cell extract or D-purified and obtained by combining known methods.
-Enzymes having aminoacylase activity can also be used. In this case, D- is obtained from the treated cells obtained by mechanically grinding cells, sonication-crushed cells, or lysozyme.
A fraction having an aminoacylase activity may be purified and used, and the purification method may be a method for purifying a normal enzyme, such as ammonium sulfate fractionation, ion-exchange chromatography, hydrophobic chromatography, affinity chromatography, etc. Can be mentioned.

【0013】菌体または菌体処理物の使用量としては、
通常の反応の場合において目的とする効果を発揮する量
(有効量)であればよく、この有効量は当業者であれば
簡単な予備実験により容易に求められるが、例えば、洗
浄湿潤菌体の場合、反応液1リットル当たり10〜40
0gである。
[0013] The amount of the cells or the treated cells is as follows.
It is sufficient that the amount (effective amount) exerts the intended effect in the case of a normal reaction, and this effective amount can be easily determined by a person skilled in the art by a simple preliminary experiment. In this case, 10 to 40 per liter of the reaction solution is used.
0 g.

【0014】アシルアミノ酸はそのまま、あるいは、水
に溶解し、または反応に影響を与えないような有機溶媒
に溶解したり、界面活性剤等に分散させたりして、反応
始めから一括にあるいは分割して添加して用いても良
い。
The acylamino acid may be used as it is, or may be dissolved in water, or dissolved in an organic solvent that does not affect the reaction, or dispersed in a surfactant or the like. It may be used after adding.

【0015】反応pHはpH3〜9、好ましくはpH5
〜8、反応温度は10〜60℃好ましくは20〜40℃
の範囲で、1〜120時間程度、撹拌下あるいは静置下
で行う。基質の使用濃度は特に制限されないが、1%〜
30%程度が好ましい。
The reaction pH is pH 3 to 9, preferably pH 5
-8, reaction temperature is 10-60 ° C, preferably 20-40 ° C
And under stirring or standing for about 1 to 120 hours. The concentration of the substrate used is not particularly limited, but is 1% to
About 30% is preferable.

【0016】反応終了後、蓄積生成したD−アミノ酸
は、反応液から、濃縮晶析、冷却晶析などの晶析方法に
より、晶析分離される。分離した粗D−アミノ酸は、再
度溶解し、活性炭などで不純物淘汰後、再結精製され
る。
After the completion of the reaction, the accumulated D-amino acid is separated from the reaction solution by crystallization such as concentration crystallization and cooling crystallization. The separated crude D-amino acid is redissolved again, and impurities are removed using activated carbon or the like, and then purified by reconstitution.

【0017】以下、実施例にて本発明を詳細に説明す
る。
Hereinafter, the present invention will be described in detail with reference to examples.

【実施例】【Example】

実施例1:新規D−アミノアシラーゼ活性する微生物に
よるD−フェニルアラニン(D-Phe)の生産 N-アセチル-D-フェニルアラニン(N-Ac-D-Phe)2g/L、
酵母エキスS(日本製薬製)10g/L、ポリペプトン(日
本製薬製) 10g/L、KH2PO4 1g/dL、K2HPO4 3g/L、MgSO4
・7H20 0.5g/L、をKOHでpH7.0に調整し、寒天20g/Lを加
えて120℃、15分間殺菌して、調製した平板培地に、あ
らかじめブイヨン寒天培地で30℃にて、24時間培養し
た、表1に示す微生物を接種し、24時間培養した。培養
後、菌体をかき取り、集めた。
Example 1: Production of D-phenylalanine (D-Phe) by a microorganism having a novel D-aminoacylase activity N-acetyl-D-phenylalanine (N-Ac-D-Phe) 2 g / L,
Yeast extract S (Nippon Pharmaceutical) 10 g / L, polypeptone (Nippon Pharmaceutical) 10 g / L, KH2PO4 1 g / dL, K2HPO4 3 g / L, MgSO4
・ 7H20 0.5 g / L was adjusted to pH 7.0 with KOH, agar 20 g / L was added and sterilized at 120 ° C. for 15 minutes, and the prepared plate medium was previously treated with bouillon agar medium at 30 ° C. for 24 hours. Microorganisms shown in Table 1 were inoculated and cultured for 24 hours. After the culture, the cells were scraped and collected.

【0018】この菌体を、150mM(31.1mg/L)のN-Ac-D-Ph
eを含む、0.1Mのリン酸緩衝液中(pH7.0)に、湿重量で5%
(w/v)になるように添加し、30℃で42時間反応を行わせ
た。反応液中の生成D-Pheを高速液体クロマトグラフィ
ー(HPLC)で定量し、その結果を表1に示した。比較
例として、公知のD−アミノ酸生産菌ストレプトマイセ
ス ツリウス(Streptomyces turius) IFO13418(特開
昭62-12969、または、Agric. Biol. Chem. 44巻 1089
頁、1980)を用いた場合の結果を示したが、今回新規に
見いだされた菌は、いずれも比較例に比べ、D-Phe生産
性が高いことが示された。なお、分析条件は、カラム
nacalaitesque COSMOSIL 5C18 4.6×50mm、及び三
菱化成MCI GEL CRS10W(DLAA)4.
6×50mmの直列通液;検出はUV254nm;移動相は、2mM
CuSO4水溶液:メタノール=85:15;流量、1.0ml/mi
n.;温度、50℃とした。リテンションタイムは、D-Phe
7.5min.、L-Phe 8.8min.である。
The cells were treated with 150 mM (31.1 mg / L) N-Ac-D-Ph
e in 0.1M phosphate buffer (pH 7.0), 5% by wet weight
(w / v) and reacted at 30 ° C. for 42 hours. The produced D-Phe in the reaction solution was quantified by high performance liquid chromatography (HPLC), and the results are shown in Table 1. As a comparative example, a known D-amino acid producing bacterium Streptomyces turius IFO13418 (Japanese Patent Application Laid-Open No. 62-12969, or Agric. Biol. Chem. 44: 1089)
Page, 1980), the results show that all of the newly found bacteria have higher D-Phe productivity than the comparative examples. The analysis conditions were column
3. nacalaitesque COSMOSIL 5C18 4.6 × 50 mm and Mitsubishi Kasei MCI GEL CRS10W (DLAA)
6 x 50 mm serial flow; detection UV 254 nm; mobile phase 2 mM
CuSO4 aqueous solution: methanol = 85:15; flow rate, 1.0 ml / mi
n .; temperature was 50 ° C. Retention time is D-Phe
7.5 min. And L-Phe 8.8 min.

【0019】[0019]

【表1】 【table 1】

【0020】実施例2:各種D-アミノ酸の生産 N-アセチル-D-フェニルアラニン 2g/L、酵母エキスS
(日本製薬製)10g/L、ポリペプトン(日本製薬製) 10
g/L、KH2PO4 1g/L、K2HPO4 03g/L、MgSO4・7H200.5g/L、
フマル酸20g/Lを含む培地(pH7.0)を500ml容フラスコに5
0mlいれ、120℃で15分間殺菌した。これにブイヨン寒天
培地で30℃にて、24時間培養した、 アースロバクター
ハイドロカーボグルタミカス ATCC15583を接種
し、24時間培養した。培養後、培養液全量を、同じ培地
2lを張り込み、同様に殺菌された小型発酵槽(5l容)に
移液し、温度30℃、撹拌速度350rpm、通気毎分1リット
ル、培養pH無制御の条件で29時間培養した。培養後、菌
体を遠心分離(10,000G、15分間)により採取した。
Example 2: Production of various D-amino acids N-acetyl-D-phenylalanine 2 g / L, yeast extract S
(Nippon Pharmaceutical) 10 g / L, Polypeptone (Nippon Pharmaceutical) 10
g / L, KH2PO4 1g / L, K2HPO4 03g / L, MgSO4.7H200.5g / L,
A medium (pH 7.0) containing 20 g / L of fumaric acid is placed in a 500 ml flask.
0 ml was added and sterilized at 120 ° C. for 15 minutes. This was inoculated with Arthrobacter hydrocarboglutamicus ATCC15583, which had been cultured at 30 ° C. for 24 hours on a bouillon agar medium, and cultured for 24 hours. After culturing, use the same medium
2 liters were poured, and the solution was transferred to a similarly sterilized small fermenter (5 liter volume), and cultured for 30 hours at a temperature of 30 ° C., a stirring speed of 350 rpm, aeration of 1 liter per minute, and no culture pH control. After the culture, the cells were collected by centrifugation (10,000 G, 15 minutes).

【0021】菌体(湿重量1g)に9mlの100mMリン酸緩
衝液(pH6.0)を加え、菌体濃厚懸濁液とした。次に各々1
0g/LのN-アセチル-D-アラニン、N-アセチル-D-バリン、
N-アセチル-D-ロイシン、N-アセチル-D-イソロイシン、
N-アセチル-D-トリプトファン、N-アセチル-D-メチオニ
ンを100mMリン酸緩衝液(pH6.0)に溶解した基質液0.5ml
に菌体濃厚懸濁液0.5mlを添加し、30℃、24時間反応を
行った。反応後、反応液中に生成されたD-アミノ酸を実
施例1と同様にHPLCで分析した結果、表2のようにな
り、各アセチルアミノ酸より良好に対応するD-アミノ酸
が得られた。
9 ml of 100 mM phosphate buffer (pH 6.0) was added to the cells (wet weight: 1 g) to obtain a concentrated cell suspension. Then each one
0 g / L N-acetyl-D-alanine, N-acetyl-D-valine,
N-acetyl-D-leucine, N-acetyl-D-isoleucine,
0.5 ml of substrate solution in which N-acetyl-D-tryptophan and N-acetyl-D-methionine are dissolved in 100 mM phosphate buffer (pH 6.0)
0.5 ml of a concentrated cell suspension was added to the mixture, and the mixture was reacted at 30 ° C. for 24 hours. After the reaction, the D-amino acids generated in the reaction solution were analyzed by HPLC in the same manner as in Example 1. As a result, the results were as shown in Table 2, and D-amino acids better corresponding to each acetyl amino acid were obtained.

【0022】[0022]

【表2】 [Table 2]

【0023】実施例3:菌体処理物である、精製酵素に
よるD−フェニルアラニンの生産 実施例2と同様に、アースロバクター ハイドロカーボ
グルタミカス ATCC15583を培養し、採取された湿重
量100gの菌体ペーストに、20mMリン酸緩衝液を40ml加
え、菌体濃厚懸濁液とした後、ビーズビーター(バイオ
スペック社製、ガラスビーズ直径0.1mmを使用)で5分
間、菌体破砕処理を行った後、20mMリン酸緩衝液(pH7.
0)を加え、全量100mlとした。デカンテーションでガラ
スビーズを除いた菌体破砕液をとり、さらに遠心分離(1
0,000G、15分間)により未破砕残査を除去した。その
後、得られた遠心分離上清に0.1gのプロタミンを加え、
核酸成分を沈殿除去させた後、これを粗酵素液とした。
Example 3 Production of D-Phenylalanine by Purified Enzyme, a Treated Cell Material As in Example 2, Arthrobacter hydrocarboglutamicus ATCC15583 was cultured, and a 100 g wet cell weight was collected. After adding 40 ml of 20 mM phosphate buffer to the paste to form a concentrated cell suspension, the cells were crushed for 5 minutes using a bead beater (manufactured by BioSpec, using a glass bead diameter of 0.1 mm). , 20 mM phosphate buffer (pH 7.
0) was added to make a total volume of 100 ml. Remove the cell lysate from which the glass beads have been removed by decantation, and further centrifuge (1
(0,000 G, 15 minutes) to remove uncrushed residue. Thereafter, 0.1 g of protamine was added to the obtained centrifuged supernatant,
After the nucleic acid component was removed by precipitation, this was used as a crude enzyme solution.

【0024】粗酵素液50mlに氷冷下、硫安を40%飽和に
なるよう添加した。その後、40%硫安飽和20mMリン酸緩
衝液(pH7.0)で平衝化したブチルトヨパール 650M カラ
ム( φ2.5 ×30cm) に通液し、酵素を吸着させた。500m
l の 40%硫安飽和同緩衝液でカラムを洗浄した後、(NH
4)2SO4 飽和度50〜0%のリニアグラジエントで酵素を溶
出させた( 流速70ml/分, 10mlずつ分画) 。活性画分(2
0%〜0%硫安飽和液での溶出画分)200mlを得た。その後、
活性画分を限外濾過膜( 排除分子量MW10,000) を用い
て、10ml に濃縮し、再度20mM リン酸緩衝液 (pH 6.0)
で透析し、精製酵素液とした。
Ammonium sulfate was added to 50 ml of the crude enzyme solution under ice-cooling so as to be 40% saturated. Thereafter, the solution was passed through a butyltoyopearl 650M column (φ2.5 × 30 cm) equilibrated with a 40% ammonium sulfate saturated 20 mM phosphate buffer (pH 7.0) to adsorb the enzyme. 500m
After washing the column with l of 40% ammonium sulfate saturated buffer, (NH
4) The enzyme was eluted with a linear gradient of 2SO4 saturation of 50 to 0% (flow rate 70 ml / min, fractionated 10 ml each). Active fraction (2
200 ml of a fraction eluted with 0% to 0% ammonium sulfate saturated solution) was obtained. afterwards,
The active fraction was concentrated to 10 ml using an ultrafiltration membrane (excluded molecular weight MW 10,000), and then reconstituted in 20 mM phosphate buffer (pH 6.0).
Dialyzed to obtain a purified enzyme solution.

【0025】20.7g/LのN-アセチル-D,L-フェニルアラニ
ンを100mM リン酸緩衝液(pH6.0)に溶解した基質液 9ml
に精製酵素液 1mlを添加し、30℃で40時間インキュベー
トした。その後、反応液を 100℃ 5分間煮沸することに
により反応を停止させ、実施例1と同じ様に、HPLCで反
応液中のフェニルアラニンの生成量を分析した。その結
果、反応液中に6.4g/LのD-フェニルアラニンが生成して
いた。また、L-フェニルアラニンはほとんど生成しなか
った。
9 ml of a substrate solution obtained by dissolving 20.7 g / L of N-acetyl-D, L-phenylalanine in 100 mM phosphate buffer (pH 6.0)
Then, 1 ml of the purified enzyme solution was added thereto, and incubated at 30 ° C. for 40 hours. Thereafter, the reaction was stopped by boiling the reaction mixture at 100 ° C. for 5 minutes, and the amount of phenylalanine produced in the reaction mixture was analyzed by HPLC in the same manner as in Example 1. As a result, 6.4 g / L of D-phenylalanine was generated in the reaction solution. L-phenylalanine was hardly produced.

【0026】[0026]

【発明の効果】上記のように、本発明によれば、アシル
アミノ酸から、容易かつ効率的に対応するD−アミノ酸
が製造可能となる。
As described above, according to the present invention, a corresponding D-amino acid can be easily and efficiently produced from an acyl amino acid.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C12P 13/22 C12P 13/22 A C //(C12P 13/06 C12R 1:06) (C12P 13/06 C12R 1:06) (C12P 13/06 C12R 1:06) (C12P 13/08 C12R 1:06) (C12P 13/12 C12R 1:06) (C12P 13/22 C12R 1:06) (C12P 13/22 C12R 1:15) (C12P 13/22 C12R 1:19) (C12P 13/22 C12R 1:18) (C12P 13/22 C12R 1:20) (C12P 13/22 C12R 1:365) (C12P 13/22 C12R 1:64) (C12P 13/22 C12R 1:465) (C12P 13/22 C12R 1:01) (C12P 13/22 C12R 1:06) (72)発明者 横関 健三 神奈川県川崎市川崎区鈴木町1−1 味の 素株式会社中央研究所内──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification symbol FI C12P 13/22 C12P 13/22 AC // (C12P 13/06 C12R 1:06) (C12P 13/06 C12R 1:06) (C12P 13/06 C12R 1:06) (C12P 13/08 C12R 1:06) (C12P 13/12 C12R 1:06) (C12P 13/22 C12R 1:06) (C12P 13/22 C12R 1:15) (C12P 13/22 C12R 1:19) (C12P 13/22 C12R 1:18) (C12P 13/22 C12R 1:20) (C12P 13/22 C12R 1: 365) (C12P 13/22 C12R 1:64) (C12P 13/22 C12R 1:01) (C12P 13/22 C12R 1:06) (72) Inventor Kenzo Yokoseki 1-1 Suzukicho, Kawasaki-ku, Kawasaki-ku, Kawasaki-shi, Kanagawa Prefecture Moto Research Co., Ltd. Inside

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】アシルアミノ酸をD−アミノ酸に変換する
能力を有し、アースロバクター(Arthrobacter)属、コリ
ネバクテリウム(Corynebacterium)属、エルビニア(E
rwinia)属、エセリシア(Escherichia)属、フラボバ
クテリウム(Flavobacterium)属、ノカルディア(Noca
rdia)属、プロタミノバクター(Protaminobacter)
属、ロドコッカス(Rhodococcus)属またはキサントモ
ナス(Xanthomonas)属に属する微生物の培養物、該培
養物より分離した微生物菌体もしくは該微生物菌体の処
理物をアシルアミノ酸に作用させ、生成されるD−アミ
ノ酸を採取することを特徴とするD−アミノ酸の製造方
法。
The present invention has the ability to convert an acyl amino acid to a D-amino acid, and has the genus Arthrobacter, Corynebacterium, and Erbinia (E).
rwinia, Escherichia, Flavobacterium, Nocardia
rdia) genus, Protaminobacter
Genus, a culture of a microorganism belonging to the genus Rhodococcus or the genus Xanthomonas, a microbial cell isolated from the culture or a processed product of the microbial cell, acting on an acyl amino acid to produce a D-amino acid A method for producing D-amino acids.
JP28007397A 1997-10-14 1997-10-14 Method for producing D-amino acid Expired - Fee Related JP3834960B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28007397A JP3834960B2 (en) 1997-10-14 1997-10-14 Method for producing D-amino acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28007397A JP3834960B2 (en) 1997-10-14 1997-10-14 Method for producing D-amino acid

Publications (2)

Publication Number Publication Date
JPH11113592A true JPH11113592A (en) 1999-04-27
JP3834960B2 JP3834960B2 (en) 2006-10-18

Family

ID=17619934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28007397A Expired - Fee Related JP3834960B2 (en) 1997-10-14 1997-10-14 Method for producing D-amino acid

Country Status (1)

Country Link
JP (1) JP3834960B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058529A4 (en) * 1998-02-03 2001-09-19 Gillette Co Deodorant composition containing d-amino acid
EP1275723A1 (en) * 2001-07-10 2003-01-15 Ajinomoto Co., Inc. Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids
WO2011158679A1 (en) 2010-06-17 2011-12-22 株式会社 資生堂 Skin improving dermo-cosmetics
WO2011158678A1 (en) 2010-06-17 2011-12-22 株式会社 資生堂 Oil-in-water type emulsion skin cosmetic
JP2014195433A (en) * 2013-03-29 2014-10-16 森永乳業株式会社 Method for production of d-amino acid
JP2015047120A (en) * 2013-08-30 2015-03-16 森永乳業株式会社 Method for production of d-amino acid
JP2015047114A (en) * 2013-08-30 2015-03-16 森永乳業株式会社 Method for production of d-amino acid

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058529A4 (en) * 1998-02-03 2001-09-19 Gillette Co Deodorant composition containing d-amino acid
EP1275723A1 (en) * 2001-07-10 2003-01-15 Ajinomoto Co., Inc. Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids
US7060485B2 (en) 2001-07-10 2006-06-13 Ajinomoto Co., Inc. DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
US7314738B2 (en) 2001-07-10 2008-01-01 Ajinomoto Co., Inc. DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
WO2011158679A1 (en) 2010-06-17 2011-12-22 株式会社 資生堂 Skin improving dermo-cosmetics
WO2011158678A1 (en) 2010-06-17 2011-12-22 株式会社 資生堂 Oil-in-water type emulsion skin cosmetic
JP2012020989A (en) * 2010-06-17 2012-02-02 Shiseido Co Ltd Skin improving dermo-cosmetic
JP2014195433A (en) * 2013-03-29 2014-10-16 森永乳業株式会社 Method for production of d-amino acid
JP2015047120A (en) * 2013-08-30 2015-03-16 森永乳業株式会社 Method for production of d-amino acid
JP2015047114A (en) * 2013-08-30 2015-03-16 森永乳業株式会社 Method for production of d-amino acid

Also Published As

Publication number Publication date
JP3834960B2 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
KR100247853B1 (en) Process for producing d-alpha-amino acid
US8460902B1 (en) DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid
US7314738B2 (en) DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
US3871963A (en) Microbial protease and preparation thereof
JP3834960B2 (en) Method for producing D-amino acid
US5702939A (en) Glucosamine-6-phosphate deaminase and process for producing the same
US4705752A (en) Process for the enzymatic hydrolysis of D-α-amino-acid amides
HU215093B (en) Process for production of amide compounds
EP0392556A1 (en) Process for producing isomaltulose
JP3014171B2 (en) Method for producing 4-halo-3-hydroxybutyramide
JPH1175885A (en) Production of calcium 2-hydroxy-4-methylthiobutanoate
GB2113691A (en) Production of l-threonine
KR950005424B1 (en) Process for producing l-aspartyl-l-phenylalanine and its diketo piperazine
JPH11137289A (en) Production of 2,6-diaminopurine-2'-deoxyriboside and 2'-deoxyguanosine
EP0220028B1 (en) Process for producing l-aspartyl-l-phenylalanine and its diketopiperazine
JP4485734B2 (en) 5-substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and method for producing optically active amino acid
JP3709007B2 (en) Process for producing fumaric acid
JP3873512B2 (en) Method for producing D-3- (2-naphthyl) alanine
JP2000152800A (en) Production of alpha-hydroxy-4-methylthiolactic acid
JPH01277499A (en) Production of l-alpha-amino acid
JP2899106B2 (en) Method for producing D-proline
WO1996031616A1 (en) Process for producing l-2-aminoadipic acid
JP2973669B2 (en) Process for producing (S)-(-)-2,3-dihalo-1-propanol
US5179009A (en) Process for producing L-aspartyl-L-phenylalanine and its diketopiperazine
JP2899071B2 (en) Method for producing L-α-alanine

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Effective date: 20060418

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060605

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060704

A61 First payment of annual fees (during grant procedure)

Effective date: 20060717

Free format text: JAPANESE INTERMEDIATE CODE: A61

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090804

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090804

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100804

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 4

Free format text: PAYMENT UNTIL: 20100804

LAPS Cancellation because of no payment of annual fees